Pain management for urinary conditions

Pain management for urinary conditions in rabbits represents a critical component of comprehensive treatment for disorders affecting the bladder, kidneys, ureters, and urethra. Rabbits commonly experience painful urinary conditions including bladder sludge, urolithiasis (urinary stones), urinary tract infections, and cystitis, all of which cause significant discomfort that can profoundly impact quality of life and recovery. Effective pain control not only improves rabbit welfare but also supports healing by reducing stress, maintaining appetite, and encouraging normal activity and hydration. A multi-modal approach to pain management, utilizing medications from different drug classes, provides the most comprehensive relief for rabbits suffering from urinary discomfort.

The mechanisms underlying urinary pain in rabbits involve both somatic and visceral pain pathways. Bladder distension, inflammation of the bladder wall, irritation from calcium carbonate sludge, and tissue damage from stones or infections all trigger pain signals through sensory nerve fibers in the urinary tract. This pain can manifest as hunched posture, reluctance to move, decreased appetite, teeth grinding, reduced grooming, and changes in urination patterns including straining, frequent small urinations, or reluctance to urinate. Understanding these pain mechanisms helps veterinarians select appropriate medications that target different aspects of the pain experience, providing more complete relief than single-agent therapy.

The primary medications used for urinary pain management in rabbits include nonsteroidal anti-inflammatory drugs (NSAIDs) such as meloxicam, opioid analgesics like buprenorphine and tramadol, and adjunctive agents that may address specific aspects of urinary pain. Meloxicam serves as the foundation of most rabbit pain protocols due to its effectiveness, safety profile, and anti-inflammatory properties that address both pain and inflammation in the urinary tract. Opioid medications provide additional pain relief for moderate to severe discomfort and work through different mechanisms than NSAIDs, making combination therapy particularly effective. The specific medications and doses are determined by the veterinarian based on the severity of the condition and individual patient factors.

Proper pain management for urinary conditions requires ongoing assessment and adjustment under veterinary supervision, as pain levels may fluctuate with disease progression or treatment response. Rabbit-savvy veterinarians recognize that rabbits are prey animals who instinctively hide pain, making careful observation and proactive pain management essential. Owners play a crucial role in monitoring their rabbit's comfort level at home and reporting changes to the veterinary team. The goal of urinary pain management extends beyond simple symptom relief to supporting overall recovery, maintaining normal eating and drinking habits, preventing secondary complications like GI stasis, and ensuring the rabbit can participate in necessary treatments such as increased fluid therapy or dietary modifications.

The primary indication for pain management in rabbit urinary conditions is bladder sludge, one of the most common urinary disorders affecting domestic rabbits. Calcium carbonate sludge accumulates in the bladder due to rabbits' unique calcium metabolism, creating a thick, paste-like material that causes chronic irritation and discomfort. Rabbits with bladder sludge often experience constant low-grade pain that worsens during urination as the sludge passes through the urethra. Pain management supports the treatment of bladder sludge by keeping the rabbit comfortable enough to maintain adequate water intake, which is essential for flushing the bladder, and by reducing inflammation that contributes to ongoing sludge accumulation.

Urinary tract infections represent another common indication for pain management in rabbits. Bacterial cystitis causes inflammation of the bladder wall, leading to significant discomfort during both bladder filling and emptying. The pain from UTIs can cause rabbits to strain excessively, urinate in inappropriate locations due to urgency, or avoid urinating altogether, which worsens the infection. While antibiotics address the underlying bacterial cause, concurrent pain management improves patient comfort during the days required for antibiotics to resolve the infection. NSAIDs are particularly valuable in this context because their anti-inflammatory effects directly address the bladder wall inflammation causing much of the discomfort.

Urolithiasis, or urinary stones, creates some of the most severe urinary pain in rabbits and requires aggressive pain management as part of treatment. Stones in the bladder cause chronic irritation and inflammation, while stones passing through the ureters or urethra cause acute, intense pain. Male rabbits with urethral stones may experience life-threatening obstruction accompanied by severe pain and distress. Pain management is essential during diagnostic workup, medical management attempts, surgical intervention, and recovery from urolithiasis. Opioid analgesics combined with NSAIDs provide the most effective relief for stone-related pain, particularly in acute or peri-surgical situations.

Secondary applications of urinary pain management include treatment of post-surgical discomfort following cystotomy or other urinary surgeries, management of pain from urinary catheterization procedures, and supportive care for rabbits with kidney disease or ureter abnormalities. Chronic kidney disease can cause discomfort related to kidney enlargement, inflammation, or secondary urinary tract effects. Interstitial cystitis, while less well-documented in rabbits than in cats, may occur and cause chronic bladder pain requiring long-term management. Pain protocols are also important during urinary diagnostic procedures such as cystocentesis or radiographic studies that require manipulation of the urinary system.

When selecting pain management approaches for urinary conditions, veterinarians consider the specific diagnosis, pain severity, duration of treatment needed, and individual patient factors. Meloxicam is typically first-line therapy for mild to moderate urinary pain due to its effectiveness and favorable safety profile in rabbits. More severe pain or inadequate response to NSAIDs alone prompts addition of opioid medications. The chronicity of the condition influences drug selection, as long-term NSAID use requires periodic monitoring while opioids are generally reserved for shorter-term management of acute pain episodes. Multi-modal protocols using medications from different classes provide superior pain control compared to single-agent therapy for moderate to severe urinary pain.

Pain management dosing for rabbit urinary conditions must be individualized based on the specific medications prescribed, the severity of pain, body weight, and ongoing assessment of response to therapy. A rabbit-savvy veterinarian determines the appropriate drug combinations and doses for each patient, as effective pain management requires professional expertise in both pain assessment and rabbit pharmacology. Pet owners should never attempt to dose pain medications without specific veterinary instructions, as many human pain medications are dangerous to rabbits and even rabbit-safe drugs require accurate dosing to be both effective and safe. The following discusses general principles of pain medication administration rather than specific doses.

Meloxicam, the most commonly used NSAID for rabbit pain management, is typically administered once daily due to its prolonged duration of action. The medication is available in liquid form designed for dogs and cats, or as compounded preparations made specifically for small animal dosing. Oral administration using a small syringe allows accurate measurement and delivery directly into the rabbit's mouth. Meloxicam can be given with or without food, though some rabbits accept it more readily when mixed with a small amount of a palatable treat like banana or unsweetened fruit puree. Consistency in timing helps maintain steady pain relief throughout the day.

Opioid medications like buprenorphine require more frequent administration than NSAIDs due to their shorter duration of action, though specific dosing intervals depend on the formulation used. Buprenorphine is available in injectable form administered subcutaneously by the veterinarian or trained owner, and increasingly in transmucosal formulations that absorb through the oral mucosa. The transmucosal route involves placing the medication under the tongue or inside the cheek, where it absorbs directly into the bloodstream. Tramadol, another opioid option, is typically given orally every eight to twelve hours and is often compounded into palatable liquids for rabbit administration. The combination of an NSAID given once daily with an opioid given multiple times daily provides comprehensive around-the-clock pain coverage.

Administering pain medications to rabbits requires gentle technique and patience to minimize stress. For oral medications, the rabbit should be securely but gently restrained, and the syringe tip inserted at the side of the mouth behind the incisors. Medication is delivered slowly to allow swallowing and prevent aspiration. Some rabbits accept medications mixed with critical care formula or hidden in favorite treats, though this method should only be used if the entire dose is reliably consumed. Injectable medications given at home require proper training from the veterinary team regarding subcutaneous injection technique, proper needle handling, and safe disposal of sharps. Owners uncomfortable with injections should discuss alternative administration routes with their veterinarian.

Missed doses of pain medication should be given as soon as remembered, with specific guidance from the veterinarian regarding timing of subsequent doses. For NSAIDs, giving a missed dose late in the day followed by the next regular morning dose is generally acceptable. For opioids with shorter dosing intervals, the veterinarian may advise skipping the missed dose if the next scheduled dose is approaching soon. Doubling doses to compensate for missed medication is never appropriate and can cause toxicity. Pet owners should contact their veterinarian if multiple doses are missed, as the rabbit may experience breakthrough pain requiring reassessment of the treatment plan.

The duration of pain management for urinary conditions varies based on the underlying diagnosis and response to treatment. Acute conditions like uncomplicated UTIs may require only a few days to a week of pain medication during antibiotic therapy. Chronic conditions like bladder sludge often need ongoing or intermittent pain management coordinated with other treatments. Surgical patients typically receive perioperative pain management that continues for several days to a week post-operatively, with tapering based on healing progress. Pain medications should not be discontinued abruptly without veterinary guidance, as this can leave the rabbit uncomfortable and may indicate a need for treatment plan reassessment.

Pain medications used for rabbit urinary conditions are generally well tolerated when properly prescribed and administered, but each drug class carries potential side effects that owners should understand. The benefits of adequate pain control typically far outweigh the risks of medication side effects, as uncontrolled pain itself causes significant harm including stress, appetite reduction, and delayed healing. Awareness of potential adverse effects enables prompt recognition and appropriate response when problems occur. Regular communication with the veterinary team helps ensure safe and effective pain management throughout treatment.

Meloxicam and other NSAIDs can cause gastrointestinal effects including mild appetite reduction or soft stools, particularly when first starting therapy. More significant concerns include potential kidney effects, as NSAIDs can reduce blood flow to the kidneys and should be used cautiously in rabbits with pre-existing kidney disease or dehydration. Gastrointestinal ulceration is a rare but serious potential complication of NSAID therapy, particularly with prolonged use or higher doses. Signs that may indicate NSAID-related problems include persistent appetite loss, dark or bloody stools, increased thirst, or changes in urination patterns. For rabbits requiring long-term NSAID therapy, periodic blood work monitoring may be recommended to assess kidney function.

Opioid medications like buprenorphine and tramadol produce predictable effects related to their mechanism of action. Sedation is the most common effect, with rabbits appearing calmer or sleepier than usual, which is often acceptable and even beneficial for painful patients needing rest. However, excessive sedation that interferes with eating or normal movement should be reported to the veterinarian for possible dose adjustment. Gastrointestinal effects of opioids include potential slowing of gut motility, which is particularly concerning in rabbits given their susceptibility to GI stasis. Owners should monitor fecal output carefully when opioids are being used and report any reduction in pellet production or appetite. Constipation can occur with opioid use and may require additional management in some rabbits.

Serious side effects requiring immediate veterinary attention include any signs of GI stasis such as not eating for more than twelve hours, significant reduction in fecal pellets, hunched posture, or abdominal distension. Allergic reactions to pain medications, while rare, may manifest as facial swelling, hives, difficulty breathing, or collapse and constitute emergencies. Signs of kidney problems including dramatically increased or decreased urination, blood in urine, or severe lethargy warrant prompt evaluation. Excessive bleeding or bruising during NSAID therapy could indicate a clotting problem. Severe sedation or respiratory depression from opioids, beyond the expected mild calming effect, requires veterinary assessment and possible dose adjustment or medication change.

Rare and idiosyncratic reactions can occur with any medication and may not be predictable based on known side effect profiles. Individual rabbits may show unusual sensitivity to specific drugs, experiencing effects at doses that would typically be well tolerated. Long-term use of any pain medication carries theoretical risks that must be weighed against the benefits of continued therapy. The veterinary team monitors for both common and unusual adverse effects and adjusts treatment protocols accordingly. Pet owners serve as essential partners in monitoring by observing their rabbit's behavior, appetite, fecal output, and overall comfort level throughout pain management therapy.

Pain medications for urinary conditions are contraindicated in rabbits with known hypersensitivity or allergic reactions to the specific drugs being considered. Previous adverse reactions to meloxicam, other NSAIDs, buprenorphine, tramadol, or related medications preclude their future use and require selection of alternative agents. Cross-reactivity within drug classes means that a rabbit allergic to one NSAID may react to others, necessitating a switch to a different medication class for pain management. Complete medication history, including any past reactions to pain relievers or anesthetics, should be discussed with the veterinarian before initiating therapy.

NSAIDs including meloxicam are contraindicated or require extreme caution in rabbits with significant kidney disease, as these medications can further compromise kidney function. Since many urinary conditions occur in rabbits with concurrent or pre-existing kidney problems, careful assessment of kidney function through blood work is often performed before starting NSAID therapy. Dehydrated rabbits should not receive NSAIDs until their fluid status is corrected, as dehydration magnifies the risk of kidney injury from these medications. Active gastrointestinal bleeding or a history of GI ulceration represents another contraindication for NSAID use due to the potential for these drugs to worsen bleeding or ulcer formation.

Pregnant and nursing rabbits require special consideration when pain management is needed for urinary conditions. Meloxicam and other NSAIDs may affect fetal development or cause complications during pregnancy and are generally avoided unless the benefit clearly outweighs the risk. Opioid medications may also pose risks during pregnancy and can affect nursing kits. Very young rabbits have immature liver and kidney function that affects drug metabolism and elimination, requiring careful dose adjustment or avoidance of certain medications. Geriatric rabbits often have some degree of organ function decline that influences drug selection and dosing, though age alone does not contraindicate appropriate pain management.

Other medical conditions may represent relative contraindications requiring individualized risk-benefit assessment. Rabbits with liver disease may have altered metabolism of both NSAIDs and opioids, potentially increasing drug levels and toxicity risk. Active GI stasis is a relative contraindication for opioid use due to the potential for further gut motility reduction, though the pain from untreated urinary conditions can itself trigger or worsen GI stasis. Rabbits with bleeding disorders or those receiving anticoagulant medications should use NSAIDs cautiously due to increased bleeding risk. Respiratory compromise may limit opioid use due to potential respiratory depression effects. Complete disclosure of all health conditions enables the veterinarian to select the safest and most effective pain management approach for each individual rabbit.

Comprehensive disclosure of all medications, supplements, and treatments the rabbit is receiving is essential when planning pain management for urinary conditions, as significant interactions can occur between pain medications and other drugs. Rabbits with urinary conditions often receive multiple concurrent therapies including antibiotics, urinary acidifiers or alkalinizers, and supportive supplements, each of which may interact with pain medications. Herbal supplements and over-the-counter products used by rabbit owners, including papaya enzyme tablets, cranberry supplements, and various herbal preparations, should all be reported to ensure safe prescribing.

NSAIDs like meloxicam interact with several commonly used medication classes in ways that may increase toxicity or reduce effectiveness. Concurrent use of multiple NSAIDs dramatically increases the risk of GI ulceration and kidney damage and should be strictly avoided. Corticosteroids combined with NSAIDs similarly elevate GI ulcer risk and should only be used together when absolutely necessary with appropriate gastroprotective measures. NSAIDs can reduce the effectiveness of certain blood pressure medications and diuretics, potentially relevant for rabbits also being treated for cardiac or fluid retention conditions. Aminoglycoside antibiotics, sometimes used for serious urinary infections, combined with NSAIDs increase the risk of kidney toxicity.

Opioid medications may interact with other drugs that affect the central nervous system, potentially causing additive sedation or respiratory depression. Sedatives, antihistamines, and certain other medications can enhance the sedative effects of buprenorphine or tramadol beyond expected levels. Tramadol has additional interaction potential due to its metabolism through liver enzymes that are affected by numerous other drugs, potentially altering tramadol blood levels and effects. Serotonergic medications, though rarely used in rabbits, can interact with tramadol to increase the risk of serotonin syndrome. The combination of different opioid medications requires careful veterinary management to avoid excessive effects.

Dietary factors and supplements relevant to urinary conditions may also influence pain medication therapy. High-calcium diets being modified as part of bladder sludge management generally do not directly interact with pain medications but are part of the overall treatment context. Probiotics given to support GI health during medication therapy generally do not interact with pain medications but help maintain gut function that can be affected by opioids. Fluid supplementation, either subcutaneous or oral, supports kidney function and may reduce NSAID-related kidney risks. The timing of pain medications relative to other treatments may be adjusted to optimize absorption and minimize interaction potential.

Monitoring for drug interactions involves both clinical observation and potentially laboratory testing. Signs of possible interactions include unexpected sedation levels, changes in medication effectiveness, GI upset beyond expected effects, or changes in urination patterns. Periodic blood work during combination therapy helps assess kidney and liver function and can detect problems before they become severe. Any new symptoms or changes in the rabbit's condition after starting pain medications or adding new treatments should prompt veterinary consultation. Maintaining a current medication list and sharing updates with all veterinary providers involved in the rabbit's care helps prevent oversight of potential interactions.

General precautions for pain management of rabbit urinary conditions emphasize the critical importance of working with a veterinarian experienced in rabbit medicine. Pain assessment in rabbits requires expertise, as these prey animals instinctively hide signs of discomfort, and both undertreatment and overtreatment carry risks. Accurate body weight measurement, ideally in grams for smaller rabbits, enables precise dosing of pain medications where small errors can significantly impact both safety and effectiveness. Pet owners should follow veterinary instructions exactly regarding medication doses, timing, and duration, and should never adjust pain medication regimens without professional guidance.

Breed-specific considerations for pain management relate primarily to body size variations among rabbit breeds. Dwarf breeds require particularly precise dosing due to their small body mass, where minor dosing errors represent proportionally larger variations. Compounded medications at appropriate concentrations facilitate accurate dosing for these small patients. Giant breeds may require higher absolute doses but are generally dosed on a milligram per kilogram basis like other rabbits. Individual variation within breeds means that each rabbit should be assessed individually for appropriate pain management regardless of breed characteristics. Some rabbits may be more or less sensitive to specific medications independent of their breed background.

Environmental precautions include proper storage of pain medications away from the rabbit's living area and out of reach of children and other pets. Multi-pet households must store medications securely, as doses appropriate for rabbits differ from those for dogs or cats, and accidental ingestion could be harmful. Human handlers should wash hands after administering medications, particularly injectable formulations. Pregnant women should consult their healthcare provider regarding handling of specific pain medications. Proper disposal of unused medications through veterinary or pharmacy take-back programs prevents environmental contamination and accidental poisoning.

Monitoring during pain management therapy requires attention to multiple parameters reflecting both treatment effectiveness and potential adverse effects. Appetite and water intake should be maintained or improved with effective pain control, as reduced eating often indicates inadequate analgesia or medication side effects. Fecal output provides a crucial indicator of GI function and should remain normal in quantity and quality throughout treatment. Activity level and posture indicate comfort, with properly managed rabbits showing normal movement and positioning rather than hunched or immobile postures. Urination patterns may initially remain altered due to the underlying condition but should not worsen with pain medication and should improve as the urinary condition resolves.

Special populations requiring enhanced precautions include geriatric rabbits with age-related organ function decline, who may need reduced doses or modified drug selection. Young rabbits have immature metabolic systems and require conservative dosing approaches. Rabbits with chronic conditions such as dental disease, E. cuniculi, or arthritis may already be receiving pain medications that must be coordinated with urinary pain management. Post-surgical patients need careful pain protocol design accounting for both surgical and underlying urinary pain. Immunocompromised rabbits benefit from particularly attentive monitoring during any medication therapy. Regular veterinary follow-up throughout pain management ensures appropriate treatment adjustment as the urinary condition progresses or resolves.

Proper storage of pain medications ensures their continued effectiveness and safety throughout the treatment period for urinary conditions. Oral medications including meloxicam liquid and tramadol preparations should be stored at room temperature away from excessive heat, light, and moisture unless specific refrigeration instructions are provided. Original containers with child-resistant caps should be used, and medications kept in secure locations such as cabinets or drawers rather than bathrooms or kitchens where temperature and humidity fluctuate. Injectable medications like buprenorphine should be stored according to product-specific labeling, with appropriate temperature conditions and protection from light maintained throughout the storage period.

Different pain medication formulations have specific storage requirements and shelf life considerations. Manufactured liquid medications typically have longer shelf lives than compounded preparations, though all should be checked for expiration dates before each use. Compounded medications commonly used for rabbits may require refrigeration and often have shorter expiration periods, typically thirty to ninety days depending on the formulation. These compounded preparations should be shaken before each use to ensure uniform drug distribution throughout the liquid. Injectable solutions should be visually inspected before use for any particles, cloudiness, or color changes that might indicate degradation, and any compromised medication should be discarded. Tablets, when prescribed, should remain in their original containers and discarded if they show crumbling, discoloration, or unusual odor.

Safe handling and disposal of pain medications protects household members, other animals, and the environment. Controlled substances like buprenorphine have additional handling and storage regulations that must be followed, and any unused portions should be returned to the veterinary clinic for proper disposal. Non-controlled pain medications can often be disposed of through pharmacy take-back programs, community medication disposal events, or following specific FDA guidance for home disposal when necessary. Flushing medications is generally not recommended due to environmental concerns unless specifically directed by product labeling. Needles and syringes used for injectable medication administration must be disposed of in proper sharps containers, which can often be obtained from veterinary clinics or pharmacies. Keeping pain medications secured away from the rabbit's enclosure is essential, as curious rabbits may chew through containers if given access, potentially resulting in overdose.

Pain management for urinary conditions can be effectively provided to rabbits of all breeds with appropriate medication selection and dosing tailored to individual patient characteristics. While breed itself does not determine pain medication choice, certain breed-associated factors influence treatment approaches. Veterinarians consider breed characteristics alongside individual health status, concurrent conditions, and specific urinary diagnosis when designing pain management protocols. Recognition of breed tendencies helps anticipate potential challenges while avoiding overgeneralization that might miss individual variation.

Dwarf breeds including Netherland Dwarfs, Holland Lops, Mini Rex, Dwarf Hotots, and similar small rabbits present dosing precision challenges due to their low body weight, typically ranging from one to two kilograms. Small errors in dose measurement represent proportionally larger variations in these tiny patients, making accurate weighing and careful medication measurement essential. Compounded medications at concentrations appropriate for small animal dosing facilitate accurate administration. Dwarf breeds should be weighed in grams rather than kilograms for the most precise dosing calculations. These small rabbits may also have proportionally smaller fluid reserves, making adequate hydration particularly important during NSAID therapy to protect kidney function.

Giant breeds such as Flemish Giants, Continental Giants, British Giants, and similar large rabbits may be more prone to certain urinary conditions including bladder sludge due to factors potentially including calcium metabolism and reduced activity levels affecting bladder emptying. Pain management dosing should be based on actual measured body weight rather than estimates, as giant breeds can vary considerably in size. These larger rabbits may have concurrent musculoskeletal issues such as arthritis or spondylosis that could be addressed with the same pain medications being used for urinary conditions, potentially simplifying the overall treatment regimen. Monitoring for adequate pain control in large rabbits requires attention to their baseline activity levels and mobility.

Other breed considerations relevant to pain management include lop-eared breeds' potential for concurrent ear conditions that might complicate sedation monitoring from opioid medications, and Rex breeds' susceptibility to pododermatitis that could affect mobility assessment. Angora and other wool breeds may show medication effects through coat quality changes or altered grooming behavior. Senior rabbits of any breed commonly develop urinary conditions requiring pain management and need careful attention to age-related organ function decline when selecting and dosing medications. Young rabbits rarely develop the chronic urinary conditions most commonly requiring extended pain management but when treatment is needed, their immature organ systems necessitate conservative approaches. Individual variation within and between breeds means that each rabbit's pain management protocol should be tailored to their specific circumstances rather than applied uniformly based on breed alone.

Meloxicam represents the foundation of pain management for most rabbit urinary conditions and serves as the standard NSAID against which alternatives are compared. Other NSAIDs occasionally used in rabbits include carprofen, though meloxicam generally has more extensive safety data in this species and is typically preferred. Ketoprofen may be used for short-term pain management, particularly in hospital settings. The selection among NSAIDs depends on individual patient factors, availability, and veterinarian preference, though meloxicam remains the most commonly prescribed option for rabbit pain management. Never substitute NSAIDs without veterinary guidance, as these medications have different potencies and duration of action requiring professional dose adjustment.

Opioid alternatives and adjuncts expand pain management options for rabbits with moderate to severe urinary pain or those unable to tolerate NSAIDs. Buprenorphine provides potent analgesia suitable for significant pain and is available in injectable and transmucosal formulations. Tramadol offers oral opioid options with easier home administration than injectable medications. Gabapentin, while primarily used for neuropathic pain, may provide additional analgesia for complex pain syndromes and is sometimes combined with other medications. Hydromorphone and morphine are occasionally used in hospital settings for severe acute pain but are not typically dispensed for home use. The specific opioid or adjunct selected depends on pain severity, administration route preferences, and individual patient response.

Complementary supportive therapies enhance pain management and support overall recovery from urinary conditions. Subcutaneous fluid therapy helps maintain hydration during illness and medication therapy, supporting kidney function and overall comfort. Probiotics support gastrointestinal health, which can be affected by pain medications, particularly opioids. Critical care feeding supplements ensure adequate nutrition for rabbits whose appetite is reduced by illness or medication effects. Unlimited grass hay remains essential for GI function regardless of other treatments. Heat therapy or warm compresses may provide local comfort for some rabbits with urinary discomfort. Physical support such as padded bedding reduces pressure on painful areas. Any changes to pain management protocols, including addition of supportive therapies or modification of medication regimens, should only be made under veterinary guidance to ensure safe and coordinated care.